129 related articles for article (PubMed ID: 7912978)
1. Expression of EGF, EGF-receptor, p53, v-erb B and ras p21 in colorectal neoplasms by immunostaining paraffin-embedded tissues.
Hayashi Y; Widjono YW; Ohta K; Hanioka K; Obayashi C; Itoh K; Imai Y; Itoh H
Pathol Int; 1994 Feb; 44(2):124-30. PubMed ID: 7912978
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical study of p53, EGF, EGF-receptor, v-erb B and ras p21 in squamous cell carcinoma of hypopharynx.
Otsu M; Hayashi Y; Amatsu M; Itoh H
Kobe J Med Sci; 1994 Dec; 40(5-6):139-53. PubMed ID: 7616733
[TBL] [Abstract][Full Text] [Related]
3. Thymoma: tumour type related to expression of epidermal growth factor (EGF), EGF-receptor, p53, v-erb B and ras p21.
Hayashi Y; Ishii N; Obayashi C; Jinnai K; Hanioka K; Imai Y; Itoh H
Virchows Arch; 1995; 426(1):43-50. PubMed ID: 7704323
[TBL] [Abstract][Full Text] [Related]
4. 'Serrated' adenoma of the colorectum, with reference to its gastric differentiation and its malignant potential.
Yao T; Kouzuki T; Kajiwara M; Matsui N; Oya M; Tsuneyoshi M
J Pathol; 1999 Apr; 187(5):511-7. PubMed ID: 10398114
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of p53 and ras p21 expression in colorectal adenomas and early carcinomas.
Ieda S; Watatani M; Yoshida T; Kuroda K; Inui H; Yasutomi M
Surg Today; 1996; 26(4):230-5. PubMed ID: 8727942
[TBL] [Abstract][Full Text] [Related]
6. Comparative clinicopathological and immunohistochemical study of ras and p53 in flat and polypoid type colorectal tumours.
Yukawa M; Fujimori T; Maeda S; Tabuchi M; Nagasako K
Gut; 1994 Sep; 35(9):1258-61. PubMed ID: 7959233
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical detection of RAS, JUN, FOS, and p53 oncoprotein expression in human colorectal adenomas and carcinomas.
Magrisso IJ; Richmond RE; Carter JH; Pross CB; Gilfillen RA; Carter HW
Lab Invest; 1993 Dec; 69(6):674-81. PubMed ID: 8264230
[TBL] [Abstract][Full Text] [Related]
8. Expression of epidermal growth factor (EGF) and epidermal growth factor receptor (EGFR) in gastric and colorectal carcinomas. An immunohistological study of 63 cases.
Karameris A; Kanavaros P; Aninos D; Gorgoulis V; Mikou G; Rokas T; Niotis M; Kalogeropoulos N
Pathol Res Pract; 1993 Mar; 189(2):133-7. PubMed ID: 8321742
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of p53 overexpression in human colonic tumors.
Darmon E; Cleary KR; Wargovich MJ
Cancer Detect Prev; 1994; 18(3):187-95. PubMed ID: 8076381
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of p53 nuclear oncoprotein in colorectal adenomas.
Pignatelli M; Stamp GW; Kafiri G; Lane D; Bodmer WF
Int J Cancer; 1992 Mar; 50(5):683-8. PubMed ID: 1347513
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of p53 protein and proliferative activity in colorectal adenoma.
Yamaguchi A; Makimoto K; Goi T; Takeuchi K; Maehara M; Isobe Y; Nakagawara G
Oncology; 1994; 51(3):224-7. PubMed ID: 7910956
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of epidermal growth factor receptor (EGF-R), epidermal growth factor (EGF) and ras p21 in cholangiocarcinoma by an immunocytochemical method.
Nonomura A; Ohta G; Nakanuma Y; Izumi R; Mizukami Y; Matsubara F; Hayashi M; Watanabe K; Takayanagi N
Liver; 1988 Jun; 8(3):157-66. PubMed ID: 2839749
[TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
14. [The results of p53 immunostaining in colorectal adenomas, early cancers, advanced cancers and their hepatic metastasis].
Saigusa N; Maruyama K; Sugimura H; Endoh Y; Baba S
Gan To Kagaku Ryoho; 1996 Jun; 23 Suppl 2():159-63. PubMed ID: 8678561
[TBL] [Abstract][Full Text] [Related]
15. Clinical importance of p53 protein in gall bladder carcinoma and its precursor lesions.
Wee A; Teh M; Raju GC
J Clin Pathol; 1994 May; 47(5):453-6. PubMed ID: 8027399
[TBL] [Abstract][Full Text] [Related]
16. High c-erbB-2 protein level in colorectal adenocarcinomas correlates with clinical parameters.
Kapitanovic S; Spaventi R; Poljak L; Kapitanovic M; Pavelic ZP; Gluckman JL; Spaventi S; Pavelic K
Cancer Detect Prev; 1994; 18(2):97-101. PubMed ID: 7912991
[TBL] [Abstract][Full Text] [Related]
17. Expression of cyclin E in colorectal adenomas and adenocarcinomas: correlation with expression of Ki-67 antigen and p53 protein.
Yasui W; Kuniyasu H; Yokozaki H; Semba S; Shimamoto F; Tahara E
Virchows Arch; 1996 Sep; 429(1):13-9. PubMed ID: 8865848
[TBL] [Abstract][Full Text] [Related]
18. Expression of mdm2 and p53 in epithelial neoplasms of the colorectum.
Hao XP; Günther T; Roessner A; Price AB; Talbot IC
Mol Pathol; 1998 Feb; 51(1):26-9. PubMed ID: 9624416
[TBL] [Abstract][Full Text] [Related]
19. An immunohistochemical study of the simultaneous expression of bcl-2 and p53 oncoproteins in epithelial tumors of the colon and rectum.
Mosnier JF; Perret AG; Vindimian M; Dumollard JM; Balique JG; Perpoint B; Boucheron S
Arch Pathol Lab Med; 1996 Jul; 120(7):654-9. PubMed ID: 8757470
[TBL] [Abstract][Full Text] [Related]
20. p53 immunoreactive stain and early colorectal adenocarcinomas.
Hirota S; Kudo S; Hosobe S; Kobayashi T; Himori M; Ikeda M; Takemoto Y; Nomoto M; Aoyagi Y; Asakura H
Eur J Cancer; 1995 Dec; 31A(13-14):2220-2. PubMed ID: 8652246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
